Key result
Oral anticoagulation is linked to ~8-fold higher odds of epistaxis rebleeding after nasal packing.
Why the study?
Patients anticoagulated with warfarin admitted with epistaxis appear to have longer hospital stays and more complicated management than controls, but this has not been prospectively studied.
Observational (n=93)
No
Odds Ratio: 8.41 (95% CI 1.03–68.78)
p-value: p=0.047
No takes yet. Share an insight, caveat, or question.
May warrant closer monitoring or alternative strategies in anticoagulated epistaxis patients; leaves open need for prospective validation.
Denholm et al. (1993) conducted an observational in Epistaxis (n=93). Oral anticoagulants vs. No oral anticoagulants was evaluated on Rebleeding requiring additional treatment or occurring within 1 week after packing removal (OR 8.41, 95% CI 1.03-68.78, p=0.047). Oral anticoagulation therapy was associated with an 8.41-fold increased odds of rebleeding in adult patients treated with Rapid Rhino nasal packing for epistaxis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: